Clinical trials
Dyspareunia trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
55 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 2 |
| 2006 | 2 |
| 2007 | 1 |
| 2010 | 4 |
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 4 |
| 2014 | 4 |
| 2015 | 1 |
| 2016 | 4 |
| 2017 | 4 |
| 2018 | 9 |
| 2019 | 3 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 3 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 33 |
| Unknown status | 7 |
| Recruiting | 6 |
| Terminated | 5 |
| Withdrawn | 1 |
| Not yet recruiting | 1 |
| Suspended | 1 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Kissei Pharmaceutical Co., Ltd. | 4 |
| Medstar Health Research Institute | 3 |
| Ohio State University Comprehensive Cancer Center | 3 |
| Corewell Health East | 2 |
| Sciton | 2 |
| TherapeuticsMD | 2 |
| TriHealth Inc. | 2 |
| University of Cincinnati | 2 |
| University of Illinois at Chicago | 2 |
| Warner Chilcott | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Dyspareunia | 55 |
| Endometriosis | 9 |
| Pelvic Pain | 9 |
| Vulvodynia | 9 |
| Dysmenorrhea | 8 |
| Sexual Dysfunction, Physiological | 7 |
| Breast Neoplasms | 6 |
| Constipation | 5 |
| Vaginismus | 5 |
| Cystitis, Interstitial | 3 |
Trials
Showing 1 to 25 of 55. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.